Companies /Healthcare

Vertex Pharmaceuticals Inc

NASDAQ: VRTX Biotechnology
$537.81
▲ $3.61 (+0.67%) today
Markets open · 3:13pm ET

VRTX Coverage Page 6

12:05pm ET
Health and Healthcare

CRISPR Wins FDA Approval for Human Trials

CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals.

Chris Lange